Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Photocure

Mindre end 1K følgere

PHO

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

Photocure is a medical technology company. The company specializes in solutions for photodynamic technology. The solutions are used to treat diseases that have caused bladder cancer and HPV. The main markets are in dermatology and oncology, where the products are used by hospitals and research institutes on a global level. The company was founded in 1993 and is headquartered in Oslo, Norway.

Læs mere
Markedsværdi
-
Aktieomsætning
-
Omsætning
525,39 mio.
EBIT %
3,88 %
P/E
-
Udbytteafkast, %
-
Finanskalender
30.7
2025

Delårsrapport Q2'25

29.10
2025

Delårsrapport Q3'25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse8.5.2025, 05.00

Photocure ASA: Results for the first quarter of 2025

Photocure
Selskabsmeddelelse8.5.2025, 05.00

Photocure ASA: Results for the first quarter of 2025

Photocure
Selskabsmeddelelse5.5.2025, 16.12

Photocure ASA: Annual general meeting held

Photocure

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse5.5.2025, 16.11

Photocure ASA: Annual general meeting held

Photocure
Selskabsmeddelelse30.4.2025, 18.57

Photocure ASA: Invitation to presentation of first quarter 2025 financial results

Photocure
Selskabsmeddelelse30.4.2025, 18.57

Photocure ASA: Invitation to presentation of first quarter 2025 financial results

Photocure
Selskabsmeddelelse29.4.2025, 06.00

Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making

Photocure
Pressemeddelelse29.4.2025, 06.00

Photocure: Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making

Photocure
Selskabsmeddelelse11.4.2025, 13.28

Photocure ASA - Notice of the Annual General Meeting 5 May 2025

Photocure
Selskabsmeddelelse11.4.2025, 13.28

Photocure ASA - Notice of the Annual General Meeting 5 May 2025

Photocure
Selskabsmeddelelse11.4.2025, 13.20

Photocure ASA: Annual Report 2024

Photocure
Selskabsmeddelelse11.4.2025, 13.19

Photocure ASA: Annual Report 2024

Photocure
Selskabsmeddelelse2.4.2025, 06.50

Photocure ASA: Transactions made under share buyback program

Photocure
Selskabsmeddelelse2.4.2025, 06.50

Photocure ASA: Transactions made under share buyback program

Photocure
Selskabsmeddelelse31.3.2025, 20.48

Photocure ASA: Transactions made under share buyback program

Photocure
Selskabsmeddelelse31.3.2025, 20.48

Photocure ASA: Transactions made under share buyback program

Photocure
Selskabsmeddelelse26.3.2025, 07.55

Photocure ASA - Share option grant to Vice President and General Manager EMEA

Photocure
Selskabsmeddelelse26.3.2025, 07.55

Photocure ASA - Share option grant to Vice President and General Manager EMEA

Photocure
Selskabsmeddelelse26.3.2025, 07.00

PHO: Photocure appoints Jane Healy as Vice President and General Manager EMEA

Photocure
Pressemeddelelse26.3.2025, 07.00

Photocure appoints Jane Healy as Vice President and General Manager EMEA

Photocure
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.